Vertebrobasilar insufficiency medical therapy

Vertebrobasilar insufficiency
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Vertebrobasilar insufficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Vertebrobasilar insufficiency medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Vertebrobasilar insufficiency medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA onVertebrobasilar insufficiency medical therapy
CDC on Vertebrobasilar insufficiency medical therapy
Vertebrobasilar insufficiency medical therapy in the news
on Vertebrobasilar insufficiency medical therapy
Directions to Hospitals Treating Vertebrobasilar insufficiency
Risk calculators and risk factors for Vertebrobasilar insufficiency medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

In the recent decades, interventional therapy became more and more important with the medical therapy as the foundation of the whole treatment.Open surgery is rarely used because its high risk of complication comparing with the catheter-based therapy.

Medical Therapy

The principle of medical therapy is reducing the atherosclerotic and thrombotic risk. 1.Aspirin (75 to 325 mg daily) is strongly recommended to prevent ischemic events, if there is no contraindications. 2.If the patient is suitable to accept asprin due to contraindictions, clopidogrel (75 mg daily) or ticlopidine (250 mg twice daily) is suggested to treat the atherosclerosis of the extracranial vertebral arteries. 3.Three schemes is suggested to treat the patients with persisitently ischemic stroke or TIA due to extracranial vertebral atherosclerosis.

• (1).Aspirin (81 to 325 mg daily)
• (2).Aspirin (81 to 325 mg daily) combinated with the extended-release dipyridamole (25 and 200 mg twice daily)
• (3).clopidogrel (75 mg daily).